HalliwellB.Free radicals, antioxidants, and human disease: Curiosity, cause or consequence. Lancet1994; 344: 721–4.
2.
LunecJ.Free radicals: Their involvement in disease processes. Ann Clin Biochem1990; 27: 173–82.
3.
BatesCJ. Vitamin analysis. Ann Clin Biochem1997; 34: 599–626.
4.
SwartzHMSwartzSM. Biochemical and biophysical applications of electron spin resonance. In: GlickD, ed. Methods of Biochemical Analysis, Vol 29. New York: John Wiley & Sons, 1985. 207–323.
5.
PouSHassettDJBritiganBECohenMSRosenGM. Problems associated with spin trapping oxygen-centred free radicals in biological systems. Anal Biochem1989; 177: 1–6.
KohnHILiversedgeM.On a new aerobic metabolite whose production by brain is inhibited by the apomorphine, emetine, ergotamine, epinephrine and menadione. J Pharm Expl Ther1944: 82: 292–300.
8.
BerheimFBerheimMLCWilburKM. The reaction between thiobarbituric acid and oxidation products of certain lipids. J Biol Chem1948; 174: 257.
9.
SinnhuberROYuTCYuTC. Characterisation of the red pigment formed in the 2-thiobarbituric acid determination of oxidative rancidity. Food Res1958; 23: 626–34.
10.
DahleLKHilEGHolmanRT. The thiobarbituric acid reaction and autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochim Biophys1962; 98: 253–61.
11.
PryorWAStanleyJPBlairE.Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of thiobarbituric acid reactive materials from prostaglandin like endoperoxides. Lipids1976: 11: 370–9.
12.
EsterbauerHLangJZadreveeSSlaterTF. Detection of malondialdehyde by high performance liquid chromatography. Methods Enzymol1984; 105: 319–28.
13.
LargilliereCMalanconSB. Free malondialdehyde in human plasma by high performance liquid chromatography. Anal Biochem1988; 170: 123–6.
14.
CarbonneauMAPenchantESessDCanioniPClereM.Free and bound malondialdehyde measured as thiobarbituric acid adduct by high performance liquid chromatography in serum and plasma. Clin Chem1991; 37: 1423–9.
15.
DraperHHSquiresFJMahmoodiHWuJAgarwalsSHadleyM.A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Rad Biol Med1993; 15: 353–63.
16.
HalliwellBGutterdigeJMC. Free Radicals in Biology and Medicine, 2nd edn.London: Clarendon Press. 1989.
17.
GutteridgeJMCTicknerTR. The characterisation of thiobarbituric acid reactivity in human plasma and urine. Anal Biochem1978; 91: 250–7.
18.
GutteridgeJMCTicknerTR. The thiobarbituric acid reactivity of bile pigments. Biochem Med1978; 19: 127–32.
19.
KnightJAPieperRKMcLellanL.Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation. Clin Chem1988; 34: 2433–8.
20.
SmithJBIngermanCMSilverMJ. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med1976; 88: 166–72.
21.
SamuelssonB.Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science1983; 220: 568–75.
22.
YagiKNishigakiIOhamaH.Assay for lipoperoxide in blood serum. Vitamins1968; 39: 105–9.
23.
SlaterTFSawyerBC. The stimulatory effects of carbon tetrachloride and other halogeno-alkanes on peroxidative reactions in rat liver fractions in vitro. Biochem J1971; 123: 805–14.
24.
SatohK.Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta1978; 90: 37–43.
25.
AsakawaTMatsushitaS.The thiobarbituric acid test for detecting lipid peroxides. Lipids1979; 14: 401–6.
26.
YagiK.A simple fluorometric assay for lipid peroxide in blood plasma. Biochem Med1976; 15: 212–6.
27.
RichardMJPortalBMeoJCoudrayCHadjianAFavierA.Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem1992; 38: 704–9.
28.
WadeCRJacksonPGVan RijAM. Quantification of malondialdehyde in plasma by ion pairing reverse phase HPLC. Biochem Med1985; 33: 291–6.
29.
NakishimaKAndoKNakamizoTAkiyamaS.Development and application of organic reagents for analysis. V. High performance liquid chromatographic determination of lipoperoxides in biological fluids with 1,3-diphenyl-2-thiobarbituric acid. Chem Pharm Bull1985; 33: 5380–4.
30.
TherasseJLemonnierF.Determination of plasma lipoperoxides by high performance liquid chromatography. J Chromatogr1987; 413: 237–41.
31.
WongISKnightJAHopferSMZhariaOLeachCNSundermanFW. Lipoperoxides in plasma measured by liquid chromatographic separation of malonaldehyde-thiobarbituric acid adduct. Clin Chem1987; 33: 214–20.
32.
TatumVLChanghitCChowCK. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids1990; 25: 226–9.
33.
YoungISTrimbleER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem1991; 28: 504–8.
34.
NielsenFMikkelsenBBNielsenJBAndersenHRGrandjeanP.Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem1997; 43: 1209–14.
35.
GutteridgeJMC. The use of standards for malondialdehyde. Anal Biochem1975; 69: 518–21.
36.
GutteridgeJMCQuinlanJG. Malondialdehyde formation from lipid peroxides in the thiobarbituric acid test; the role of lipid radicals, iron salts and metal chelators. J Appl Biochem1983; 5: 293–9.
37.
GutteridgeJMCWinyardPGBlakeDRLunecJBrailsfordSHalliwellB.The behaviour of caeruloplasmin in stored human extracellular fluids in relation to feroxidase II activity, lipid peroxidation and phenathroline-detectable copper. Biochem J1985; 230: 517–23.
38.
StringerMDGorogPGFreemanAKakkarVV. Lipid peroxides and atherosclerosis. BMJ1989; 298: 281–4.
39.
LeeDM. Malondialdehyde formation in stored plasma. Biochim Biophys Res Comm1980; 95: 1663–72.
40.
HendriksTAssmanRFTA. On the fluorometric assay of circulating lipoperoxides. Clin Chim Acta1988; 174: 263–70.
41.
KnightJASmithSEKinderVEAnstallHB. Reference intervals for plasma lipoperoxides; age, sex and specimen related variations. Clin Chem1987; 33: 2289–91.
42.
ChiricoSSmithCMarchantCMitchinsonMJHalliwellB.Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Rad Res Comm1993; 91: 51–7.
43.
JentzschAMBachmannHFurstPBiesalskiHK. Improved analysis of malondialdehyde in human body fluids. Free Rad Biol Med1996; 20: 251–6.
44.
CramerLGMillerJFPendletonRBLandsWE. Iodometric measurement of lipid hydroperoxides in human plasma. Anal Biochem1991; 193: 204–11.
45.
JiangZYHungJVWolffSP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem1992; 202: 384–9.
46.
GuptaBL. Microdetermination techniques for hydrogen peroxide in irradiated solution. Microchem J1973; 18: 363–74.
47.
Nouroog-ZadehJTajaddini-SormadiJWolffSP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation—xylenol orange assay in conjuction with triphenyl phosphine. Anal Biochem1994; 220: 403–9.
48.
WolffSP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol1994; 233: 182–9.
49.
KneepkensCMFLepageGRoyCC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad Biol Med1994; 17: 127–60.
50.
MendisSSobotkaPAEularDE. Pentane and isoprene in expired air from humans: Gaschromatographic analysis of single breath. Clin Chem1994; 40: 1485–8.
51.
BahdraSArshadMAQRymazewskiANormanESubbiahMTR. Peroxidation of cholesterol moiety of low density lipoproteins in the presence of human endothelial cells or Cu++ ions: Identification of major products and their effects. Biochem Biophys Res Comm1991; 176: 431–40.
52.
ArshadMAQBhadraSCohenRMSubbiahMTR. Plasma lipoprotein peroxidation potential: A test to evaluate-individual susceptibility to peroxidation. Clin Chem1991; 37: 1756–8.
53.
AddisPBEmanuelHABergmanSDZavoralJH. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Rad Biol Med1989; 7: 179–82.
54.
SubbiahMTRYunkerRL. Evidence for the presence of non-lipoprotein factors in diabetic serum capable of stimulating rat hepatic cholesterol 7 alpha hydroxylase in vitro. Biochem Biophys Res Comm1984; 121: 743–8.
55.
AwadJAMorrowJDTakahashiKRobertsLJ. Identification of non-cyclooxygenase-derived prostanoid (F2-lsoprostane) metabolites in human urine and plasma. J Biol Chem1993; 268: 4161–9.
56.
MorrowJDFreiBAtkinsonWLGazianoJMLynchSMShyrYIncrease in circulating products of lipid peroxidation (F2-Isoprostanes) in smokers. N Engl J Med1995; 332: 1198–2203.
57.
RecknagelORGhoshalAK. Quantitative estimation of peroxidative degeneration of rat liver microsomal and mitochondrial lipids after carbon tetrachloride poisoning. Exp Mol Pathol1966; 5: 413–26.
58.
RecknagelORGhoshalAK. Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity. Lab Invest1966; 15: 132–48.
LunecJHalloranSPWhiteAGDormandyTL. Free radical oxidation products in serum and synovial fluid. J Rheumatol1981; 8: 233–45.
61.
JenningsPEJonesAFFlorkowskiCMLunecJBarnettAH. Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med1987; 4: 452–6.
62.
CorongiuFPMiliaA.An improved and simple method for determining diene conjugation in autoxidised polyunsaturated fatty acids. Chem Biol Interactions1983; 44: 289–97.
63.
SitunayakeRDCrumpBJZezulkaAVDavisMMcConkeyBThurnhamDI. Measurement of conjugated dienes by derivative spectroscopy in heptane extracts of plasma. Ann Clin Biochem1990; 27: 258–66.
64.
FolchJLeesMSloane-StanleyGH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem1957; 226: 497–509.
65.
IversenSACawoodPMadiganMJLawsonAMDormandyTL. Identification of a diene conjugated component of human lipid as octadeca −9, 11-dienoic acid. FEBS Lett1984; 171: 320–4.
66.
IversenSACawoodPDormandyTL. A method for the measurement of a diene-conjugated derivative of linoleic acid, 18:2(9,11), in serum phospholipid, and possible origins. Ann Clin Biochem1985; 22: 137–40.
67.
ThompsonSSmithMT. Measurement of the diene conjugated form of linoleic acid in plasma by high performance liquid chromatography: A questionable non-invasive assay of free radical activity?Chem Biol Interactions1985; 55: 357–66.
68.
BrittonMFongCWickensDYudkinJ.Diet as a source of phospholipid esterified 9,11-octadeca-dienoic acid in humans. Clin Sci1992; 83: 97–101.
69.
FletcherBLTappelAL. Fluorescent modification of serum albumin by lipid peroxidation. Lipids1971; 6: 172–5.
70.
GutteridgeJMCWilkinsS.Copper salt dependent hydroxyl radical formation. Damage to proteins acting as antioxidants. Biochem Biophys Acta1983; 759: 38–41.
71.
LunecJ.Fluorescence as a marker of free radical damage induced in human globulins. Biochem Soc Trans1982; 10: 21.
72.
WickensDGNordenAGLunecJDormandyTL. Fluorescent changes in human gamma globulin induced by free radical activity. Biochem Biophys Acta1983; 742: 607–16.
73.
LunecJBlakeDRMcClearySJBrailsfordSBaconPA. Self perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest1985; 76: 2084–90.
74.
JonesAFJenningsPEWakefieldAWinklesWJBarnettAH. Fluorescence of albumin and immunoglobulin G measured by HPLC with fluorescence detection. Diabetic Med1988; 5: 547–51.
75.
WolffSPGarnerADeanRT. Free radicals, lipids and protein degradation. TIBS1986; 11: 27–31.
76.
LevineRLGarlandDOliverCNAmiciAClimentILenzAGDetermination of carbonyl content in oxidatively modified proteins. Methods Enzymol1990; 186: 464–78.
77.
WolffSPDeanRT. Fragmentation of protein by free radicals and its effect on their susceptibility to enzyme hydrolysis. Biochem J1986; 234: 399–403.
78.
PacificiEDaviesKJA. Protein degradation as an index of oxidative stress. Methods Enzymol1990; 186: 485–502.
79.
HalliwellBGutteridgeJMCCrossC-E.Free radicals, antioxidants, and human disease: Where are we now?J Lab Clin Med1992; 119: 598–620.
80.
BlountSGriffithsHRLunecJ.Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Molec Aspects Med1991; 12: 93–105.
81.
TagessonCKallbergMKlintenbergCStarkhammerH.Determination of urinary 8-hydroxydeoxyguanosine by automated coupled column high performance liquid chromatography: A powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur J Cancer1995; 31A: 934–40.
82.
AmesBNCathcartRScwiersEHochsteinP.Uric acid provides an antioxidant defence in humans against oxidant and radical caused ageing and cancer; a hypothesis. Proc Natl Acad Sci USA1981; 78: 6858–62.
83.
KaurHHalliwellB.Action of biologically relevant oxidising species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact1990; 73: 235–67.
84.
CrossCEMotchnickPA. Bruener BA. Oxidative damage to plasma constituents by ozone. FEBS Lett1992; 298: 269–72.
85.
GrootveldMHalliwellB.Measurement of allantoin and uric acid in human body fluids. A potential index of free radical activity in vivo?Biochem J1987; 243: 803–8.
86.
FloydRAWatsonJJWongPK. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Meth1984; 10: 221–35.
87.
GrootveldMHalliwellB.Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Biochem J1986; 237: 499–504.
88.
GrootveldMHalliwellB.2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem Pharmacol1988; 37: 271–80.
89.
Ingelman-SundbergMKaurHTereliusYPerssonJ-OHalliwellB.Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Biochem J1991; 276: 753–7.
90.
BrigeliusRLenzenRSiesH.Increase in hepatic mixed disulphides and glutathione disulphide level elicited by paraquat. Biochem Pharmacol1982; 31: 1637–41.
DiMonteMRossDBellomoGEklowLOrreniusS.Alterations in intracellular thiol homoeostasis during the metabolism of menadione in isolated rat hepatocytes. Arch Biochem Biophys1984; 235: 334–42.
93.
TietzeF.Enzymic method for the quantitative determination of nanogram amounts of total and oxidised glutathione. Anal Biochem1969; 27: 502–22.
94.
HughesHJaeschkeHMitchellJR. Measurement of oxidant stress in vivo. Methods Enzymol1990; 186: 681–5.
95.
GriffithOW. Determination of glutathione and glutathione disulphide using glutathione reductase and 2-vinylpyridine. Anal Biochem1980; 106: 207–12.
96.
TeareJPPunchardNAPowellJJLumbPJMitchellWDThompsonRPH. Automated spectrophotometric method for determining oxidised and reduced glutathione in liver. Clin Chem1993; 39: 686–9.
97.
ReedDJBabsonJRBeattyPWBrodieAEEllisWWPotterDW. High performance liquid chromatography analysis of nanogram levels of glutathione, glutathione disulphide and related thiols and disulphides. Anal Biochem1980; 106: 55–62.
98.
HarveyPRCIlsonRGStrasburgSM. The simultaneous determination of oxidised and reduced glutathiones in liver tissue by ion pairing reverse phase high performance liquid chromatography with a coulometric detector. Clin Chim Acta1989; 180: 203–12.
99.
AnderssonAIsakssonABrattstromAHultbergB.Homocysteine and other thiols determined in plasma by HPLC and thiol-specific post column derivatization. Clin Chem1993; 39: 1590–7.
100.
LeroyPNicholasAWellmanMMicheletFOsterTSiestG.Evaluation of O-phthalaldehyde as bifunctional fluorogenic post-column reagent for glutathione in LC. Chromatographia1993; 36: 130–4.
101.
MicheletFGueguenRLeroyPWellmanMNicholasASiestG.Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables, and life habits. Clin Chem1995; 41: 1509–17.
102.
RichieJPJrSkowronskiLAbrahamPLeutzingerY.Blood glutathione concentrations in a large-scale human study. Clin Chem1996; 42: 64–70.
103.
KasparekS. In: MachlinLJ, ed. Chemistry of Tocopherols and Tocotrienols in Vitamin E: A Comprehensive Treatise. New York: Marcel Dekker Inc, 1980.
104.
HorwittMK. The term alpha-tocopherol should not be used without clarification. Am J Clin Nutr1991; 54: 760.
105.
GutteridgeJMCHalliwellB. In: Antioxidants in Nutrition, Health and Disease. Oxford: Oxford University Press, 1994: 53–4.
106.
ThompsonJNErdodyPMaxwellWB. Simultaneous fluorometric determinations of vitamins A and E in human serum and plasma. Biochem Med1973; 8: 403–11.
107.
CatignaniGLBieriJG. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem1983; 29: 708–12.
108.
NierenbergDWLesterDC. Determination of vitamins A and E in serum and plasma using a simplified clarification method and high-performance liquid chromatography. J Chromatogr1985; 345: 275–84.
109.
MillerKWYangCS. An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, alpha-tocopherol, and various carotenoids. Anal Biochem1985; 145: 21–6.
110.
HuangMLBurckartGJVenkataramananR.Sensitive high-performance liquid chromatographic analysis of plasma vitamin E and vitamin A using amperometric and ultraviolet detection. J Chromatogr1986; 380: 331–8.
111.
ArnaudJFortisIBlachierSKiaDFavierA.Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr1991; 572: 103–16.
112.
GunterEWDriskellWJYeagerPR. Stability of vitamin E in long-term stored serum. Clin Chim Acta1988; 175: 329–36.
113.
HsingAWComstockGWPolkBF. Effect of repeated freezing and thawing on vitamins and hormones in serum. Clin Chem1989; 35: 2145.
114.
EdmondsBKNierenbergDW. Serum concentrations of retinol, d-alpha-tocopherol and Beta-carotene: Effects of storage at − 70°C for five years. J Chromatogr1993; 614: 169–74.
115.
SierraCPastorMCde RamónM.Liquid chromatography determination of alpha-tocopherol in erthyrocytes. Clin Chim Acta1992; 208: 119–26.
116.
RiemersmaRAWoodDAMacIntyreCCAEltonRAGeyKFOliverMF. Risk of angina pectoris and plasma concentrations of vitamin A, C and E and carotene. Lancet1991; 337: 1–5.
117.
BehrensWAThompsonJNMadèreR.Distribution of α-tocopherol in human plasma lipoproteins. Am J Clin Nutr1982; 35: 691–6.
118.
ThurnhamDIDaviesJACrumpBJSitunayakeRDDavisM.The use of different lipids to express serum tocopherol: Lipid ratios for the measurement of vitamin E status. Ann Clin Biochem1986; 23: 514–20.
119.
LevineM.New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med1986; 314: 892–902.
120.
SauberlichHGoadWCSkalaJHWaringPP. Procedure for mechanised (continuous-flow) measurement of serum ascorbic acid (vitamin C). Clin Chem1976; 22: 105–10.
121.
CammackJOkeA.Adams RN. Simultaneous high performance liquid chromatographic determination of ascorbic acid and dehydroascorbic acid in biological samples. J Chromatogr1991; 565: 529–32.
122.
LiauLSLeeBLNewALOngCN. Determination of plasma ascorbic acid by high performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr1993; 612: 63–70.
123.
ParviainenMTMyyosönenKPenttiläIMSeppänenKRauremanRSalonenJTSA method for routine assay of plasma ascorbic acid using high-performance liquid chromatography. J Liq Chromatogr1986; 9: 2185–97.
124.
DhariwalKRHartzellWOLevineM.Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr1991; 54: 712–6.
125.
MargolisSAPauleRCZieglerRG. Ascorbic and dehydroascorbic acids measured in plasma preserved with dithiothreitol or metaphosphoric acid. Clin Chem1990; 36: 1750–5.
126.
BradleyDWEmeryGMaynaudJE. Vitamin C in plasma: A comparative study of the vitamin stabilised trichloroacetic acid or metaphosphoric acid and the effects of storage at − 70, −20, 4°, and 25° on the stabilised vitamin. Clin Chim Acta1973; 44: 47–52.
127.
MargolisSADavisTP. Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement. Clin Chem1988; 34: 2217–23.
128.
BodeAMCunninghamLRoseRC. Spontaneous decay of oxidised ascorbic acid (Dehyro-L-Ascorbic acid) evaluated by high-pressure liquid chromatography. Clin Chem1990; 36: 1807–9.
129.
LöwikMRHSchrijerJWedelM.Vitamin C analysis in whole blood, plasma and cells using reduced glutathione as preservative (stabilizer): Losses and distribution. Int J Vit Nutr Res1991; 61: 43–5.
130.
ParviainenMTSalonenJT. Vitamin C status of 54-year-old eastern Finnish men throughout the year. Int J Vit Nutr Res1990; 60: 47–51.
131.
JacobRASkalaJHOmayeST. Biochemical indices of human vitamin C status. Am J Clin Nutr1987; 46: 818–26.
132.
MilneDBBotnenJ.Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem1986; 32: 874–6.
133.
ThurnhamDISmithEFloraPS. Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem1988; 34: 377–81.
134.
KrinskyNI. Antioxidant functions of carotenoids. Free Rad Biol Med1989; 7: 617–35.
135.
CraftNEBrownEDSmithJC. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol and tocopherol in plasma. Clin Chem1988; 34: 44–8.
136.
ThurnhamDIFloraPS. Stability of individual carotenoids, retinol, and tocopherol in stored plasma. Clin Chem1988; 34: 1947.
137.
GregoryJFosterKTylerHWisemanM. In: The Dietary and Nutritional Survey of British Adults. London: HMSO, 1990.
138.
RushinWGCatignaniGLSchwartzSJ. Determination of β-carotene and its cis isomers in serum. Clin Chem1990; 36: 1986–9.
139.
MillerH.Relationship between catalase and haemoglobin in human blood. Biochem J1958; 68: 275–82.
140.
GóthL.Serum catalase: Reversibly formed charge isoform of erythrocyte catalase. Clin Chem1991; 37: 2043–7.
141.
BeersRFSizerIW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem1952; 95: 133–40.
142.
Van LenteFPepoyM.Coupled-enzyme determination of catalase activity in erythrocytes. Clin Chem1990; 36: 1339–43.
143.
YasminehWGChungM-YCaspersJI. Determination of serum catalase activity on a centrifugal analyzer by an NADP/NADPH coupled enzyme reaction system. Clin Biochem1992; 25: 21–7.
144.
GóthL.A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta1991; 196: 143–52.
145.
LamoureuxGBourdeauSDuboisGCharbonneauRGagnonMGradBR. A rapid method for determining catalase in human blood. Clin Chim Acta1987; 167: 105–11.
146.
GuemouriLArturYHerbethBJeanelCCunyGSiestG.Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem1991; 37: 1932–7.
147.
AvissarNWhitinJCAllenPZPalmerISCohenHJ. Antihuman plasma glutathione peroxidase antibodies: Immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma. Blood1989; 73: 318–23.
TakahashiKCohenHJ. Selenium-dependent glutathione peroxidase protein and activity: Immunological Investigations on cellular and plasma enzymes. Blood1986; 68: 640–5.
150.
PagliaDEValentineWN. Studies on the quantitative and qualitative characterization of erthyrocyte glutathione peroxidase. J Lab Clin Med1967; 70: 158–69.
151.
Ceballos-PicotITrivierJ-MNicoleASinetPMTheveninM.Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem1992; 38: 66–70.
152.
McMasterDBellNAndersonPLoveAHG. Automated measurement of two indicators of human selenium status, and applicability to population studies. Clin Chem1990; 36: 211–6.
153.
HopkinsJTudhopeGR. Glutathione peroxidase in human red cells in health and disease. Br J Haem1973; 25: 563–75.
154.
CapelIDJennerMWilliamsDCDonaldsonDNathA.The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. J Steroid Biochem1981; 14: 729–32.
155.
UrsiniFBindoliA.The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids1987; 44: 255–76.
156.
GutteridgeJMC. Superoxide dismutase (Erythrocuprein) and free radicals in clinical chemistry. Ann Clin Biochem1976; 13: 393–8.
157.
McCordJMFridovichI.Superoxide dismutase, an enzymic function for erythocuprein. J Biol Chem1969; 244: 6049–55.
158.
WeisigerRAFridovichI.Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localisation. J Biol Chem1973; 248:4793–6.
159.
MarklundSLHolmeEHellnerL.Superoxide dismutase in extracellular fluids. Clin Chim Acta1982; 126: 41–51.
160.
GoldsteinSMichelCBorsWSaranMCzapskiG.A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Rad Biol Med1988; 4: 295–303.
161.
BolannBJUlvikJ.Improvement of a direct spectrophotometric assay for routine determination of superoxide dismutase. Clin Chem1991; 37: 1993–9.
162.
KurobeNSuzukiFOkajimaKKatoK.Sensitive enzyme immunoassay for human Cu/Zn superoxide dismutase. Clin Chim Acta1990; 187: 11–20.
163.
KurobeNInagakiTKatoK.Sensitive enzyme immunoassay for human Mn superoxide dismutase. Clin Chim Acta1990; 192: 171–80.
164.
AdachiTOhtaHYamadaHFutenmaAKatoKHiranoK.Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta1992; 212: 89–102.
165.
StrangeRCJonesPBicknellJScarpelloJ.Expression of Cu Zn-superoxide dismutase and glutathione peroxidase in erythrocytes from diabetic and non-diabetic subjects. Clin Chim Acta1992; 207: 261–3.
166.
GutteridgeJMC. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS1983; 157: 37–40.
167.
GutteridgeJMC. In: Antioxidant Activity of Caeruloplasmin. In: CRC Handbook of Methods for Oxygen Radical Research. London: CRC Press, 1987: 303–7.
168.
GoldsteinIMKaplanHBEdelsonHSWeissmannG.Caeruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem1979; 254: 4040–5.
169.
SatoMSchilskyMLStockertRJMorellAGSternliebI.Detection of multiple forms of human ceruloplasmin. J Biol Chem1990; 265: 2533–7.
170.
EvansPJBomfordAHalliwellB.Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease. Free Rad Res Comm1989; 7: 55–62.
171.
WinyardPGHiderRCBrailsfordSDrakeAFLunecJBlakeDR. Effects of oxidative stress on some physicochemical properties of caeruloplasmin. Biochem J1989; 258: 435–45.
172.
SchosinskyKHLehmannHPBeelerMF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem1974; 20: 1556–63.
173.
MukerjeeH.A kinetic method for determination of serum ceruloplasmin. Clin Chem1990; 36: 391–2.
174.
JohnsonDAOsakiSFriedenE.A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums. Clin Chem1967; 13: 142–50.
175.
LouroMOTutorJCPazJM. Serum and plasma ceruloplasmin in humans. J Clin Chem Clin Biochem1989; 27: 511–3.
176.
MillerNJRice-EvansCGopinathanVDaviesMJMilnerA.A new automated method for estimating plasma antioxidant activity and its application to the investigation of antioxidant status in premature neonates: In: CoronginFBanniSDessiSDessiMARice-EvansC, eds. Free Radicals and Antioxidants in Nutrition. London: Richelieu Press, 1993: 153–68.
177.
WaynerDDMBurtonGWIngoldKUBarclayLRCLockeSJ. The relative contributions of Vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta1987; 924: 408–19.
178.
MillerNJRice-EvansCDaviesMJGopinathanVMilnerA.A novel method for measuring antioxidant capacity and its application for monitoring the antioxidant status in premature neonates. Clin Sci1993; 84: 407–12.
179.
GoodeHFRichardsonNMyersDSHowdlePDWalkerBEWebsterNR. The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem1995; 32: 413–6.
180.
PunchardNAKellyFJ, eds Free Radicals: A Practical Approach. Oxford: Oxford University Press, 1996.
181.
YoungISPurvisJALightbodyJHAdgeyAAJTrimbleER. Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction. Eur Heart J1993; 14: 1027–33.
182.
DandonaPThusuKCookSSynderBMakowskiJArmstrongEOxidative damage to DNA in diabetes mellitus. Lancet1996; 347: 444–5.